The Role of Alpha Therapy in Metastatic Castration Resistance Prostate Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Role of Alpha Therapy in Metastatic Castration Resistance Prostate Cancer

Published:2023-09-01 Issue:2 Volume:9 Page:102-108
ISSN:2149-6447
Container-title:Nuclear Medicine Seminars
language:
Short-container-title:nts

Author:

Alan Selçuk Nalan^ORCID,Akçay Kaan^ORCID,Kabasakal Levent^ORCID

Publisher

Galenos Yayinevi

Subject

General Medicine

Reference39 articles.

1. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020;Cao;Chin Med J (Engl),2021

2. Prostate Cancer: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up;Parker;Ann Oncol,2020

3. Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisions;Iacovelli;Crit Rev Oncol Hematol,2019

4. First-line Systemic Therapy for Metastatic Castration-Sensitive Prostate Cancer: An Updated Systematic Review With Novel Findings;Ferro;Crit Rev Oncol Hematol,2020

5. Prednisone plus cabazitaxel or mitoxantrone for metastaticcastration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial;de Bono;Lancet,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3